Progyny, Inc. (PGNY)Healthcare | Healthcare Plans | New York, United States | NasdaqGS
27.69 USD
+0.24
(0.856%)
⇧
(Oct. 16, 2026, 9:52 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 9:23 a.m. EDT
Progyny presents a compelling dichotomy: a fundamentally resilient business trading at a discount, currently weighed down by severe short-term technical weakness and a lack of income yield. The long-term story remains intact. Despite a brutal 52.9% drop in 2024, the company has staged a robust recovery, posting a +22.2% gain last year and a +99% surge five years ago. Fundamentals are solid: the balance sheet is fortress-like with minimal debt ($27M vs $237M cash), generating strong free cash flow and maintaining healthy margins. The forward P/E of 12x suggests the market has priced in significant pain, creating a margin of safety for patient capital. However, the multi-year trajectory shows volatility rather than a structural decline, as the stock is currently up significantly from its 2024 lows. Short-term, the setup is messy. The stock is trapped between its 50-day and 200-day averages, showing no clear momentum breakout despite the positive earnings surprise. The recent price action has been choppy, failing to capitalize on the 'Strong Buy' analyst consensus. The statistical forecast model offers no directional guidance, reflecting the noise in the immediate term. Crucially, there is no dividend to provide a floor or income stream; the payout history is empty. This makes the investment purely speculative on price appreciation. While the options market is screaming 'bullish' with heavy call positioning, the underlying price action hasn't confirmed the move yet. Investors should view this as a high-conviction long-term turnaround play that requires patience, rather than a tactical trade for the next few weeks. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.122050 |
| AutoETS | 0.123058 |
| MSTL | 0.125854 |
| AutoTheta | 0.131123 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 37% |
| H-stat | 2.68 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.024 |
| Excess Kurtosis | -0.61 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.95 |
| Revenue per Share | 15.87 |
| Market Cap | 2,124,565,120 |
| Trailing P/E | 30.10 |
| Forward P/E | 11.94 |
| Beta | 1.02 |
| Profit Margins | 6.00% |
| Website | https://www.progyny.com |
As of Oct. 10, 2026, 9:23 a.m. EDT: Speculators are overwhelmingly bullish, with open interest heavily skewed toward calls (98% OTM concentration) compared to negligible put activity. The massive volume and open interest at the $30 strike for October expiration suggest a consensus bet on a move above current levels, while the lack of protective puts indicates a willingness to take directional risk rather than hedge against downside.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.41959667 |
| Address1 | 1,359 Broadway |
| All Time High | 68.32 |
| All Time Low | 13.29 |
| Ask | 35.25 |
| Ask Size | 2 |
| Audit Risk | 4 |
| Average Analyst Rating | 1.4 - Strong Buy |
| Average Daily Volume10 Day | 1,123,460 |
| Average Daily Volume3 Month | 1,126,178 |
| Average Volume | 1,126,178 |
| Average Volume10Days | 1,123,460 |
| Beta | 1.02 |
| Bid | 19.61 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 5.904 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 6 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 27.69 |
| Current Ratio | 2.137 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 27.77 |
| Day Low | 27.41 |
| Debt To Equity | 5.95 |
| Display Name | Progyny |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,786,049,100 |
| Earnings Call Timestamp Start | 1,786,049,100 |
| Earnings Growth | 0.789 |
| Earnings Quarterly Growth | 0.639 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | 125,572,000 |
| Ebitda Margins | 0.0958 |
| Enterprise To Ebitda | 15.104 |
| Enterprise To Revenue | 1.447 |
| Enterprise Value | 1,896,579,200 |
| Eps Current Year | 2.08357 |
| Eps Forward | 2.31977 |
| Eps Trailing Twelve Months | 0.92 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 26.5127 |
| Fifty Day Average Change | 1.1773014 |
| Fifty Day Average Change Percent | 0.04440519 |
| Fifty Two Week Change Percent | 41.959667 |
| Fifty Two Week High | 33.065 |
| Fifty Two Week High Change | -5.374998 |
| Fifty Two Week High Change Percent | -0.16255854 |
| Fifty Two Week Low | 16.1 |
| Fifty Two Week Low Change | 11.59 |
| Fifty Two Week Low Change Percent | 0.71987575 |
| Fifty Two Week Range | 16.1 - 33.065 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,572,010,200,000 |
| Float Shares | 70,228,805 |
| Forward Eps | 2.31977 |
| Forward P E | 11.936528 |
| Free Cashflow | 196,469,376 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 835 |
| Fullday Change | 0.23500061 |
| Fullday Change Percent | 0.8559483 |
| Fullday Price | 27.69 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.24573 |
| Gross Profits | 322,088,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01979 |
| Held Percent Institutions | 1.09103 |
| Implied Shares Outstanding | 76,726,798 |
| Industry | Healthcare Plans |
| Industry Disp | Healthcare Plans |
| Industry Key | healthcare-plans |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. |
| Long Name | Progyny, Inc. |
| Market | us_market |
| Market Cap | 2,124,565,120 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_114326063 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | 78,633,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,981,853,192 |
| Number Of Analyst Opinions | 12 |
| Open | 27.65 |
| Operating Cashflow | 201,248,000 |
| Operating Margins | 0.11413 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Phone | 212 888 3124 |
| Previous Close | 27.455 |
| Price Eps Current Year | 13.289691 |
| Price Hint | 2 |
| Price To Book | 4.690041 |
| Price To Sales Trailing12 Months | 1.6208601 |
| Profit Margins | 0.05999 |
| Quick Ratio | 2.059 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.41667 |
| Region | US |
| Regular Market Change | 0.23500061 |
| Regular Market Change Percent | 0.8559483 |
| Regular Market Day High | 27.77 |
| Regular Market Day Low | 27.41 |
| Regular Market Day Range | 27.41 - 27.77 |
| Regular Market Open | 27.65 |
| Regular Market Previous Close | 27.455 |
| Regular Market Price | 27.69 |
| Regular Market Time | 1,792,158,753 |
| Regular Market Volume | 53,939 |
| Return On Assets | 0.10143 |
| Return On Equity | 0.16242 |
| Revenue Growth | 0.053 |
| Revenue Per Share | 15.87 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 6 |
| Shares Outstanding | 76,726,798 |
| Shares Percent Shares Out | 0.0664 |
| Shares Short | 5,091,022 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 4,451,388 |
| Short Name | Progyny, Inc. |
| Short Percent Of Float | 0.0938 |
| Short Ratio | 4.43 |
| Source Interval | 15 |
| State | NY |
| Symbol | PGNY |
| Target High Price | 40.0 |
| Target Low Price | 30.0 |
| Target Mean Price | 34.41667 |
| Target Median Price | 35.0 |
| Total Cash | 236,924,992 |
| Total Cash Per Share | 3.088 |
| Total Debt | 26,970,000 |
| Total Revenue | 1,310,764,032 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.92 |
| Trailing P E | 30.097826 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 24.262526 |
| Two Hundred Day Average Change | 3.427475 |
| Two Hundred Day Average Change Percent | 0.14126621 |
| Type Disp | Equity |
| Volume | 53,939 |
| Website | https://www.progyny.com |
| Zip | 10,018 |